Navigation Links
Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
Date:5/5/2008

irst product, the Boomerang Wire System, was approved in EU countries and in the U.S. in 2004. Cardiva's second-generation product, the Boomerang Catalyst System, was approved in March 2007 and launched in July 2007. The enhanced Boomerang Catalyst, trade named as "Boomerang Catalyst II System" received 510(K) clearance in September 2007 and launched in January 2008. Cardiva was selected by Frost & Sullivan as the recipient of the 2006 Frost & Sullivan Award for Entrepreneurial Company in the U.S. angioplasty and vascular closure devices market. For additional information about Cardiva please see our website at http://www.cardivamedical.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Cardiva's current expectations and actual results could differ materially. Cardiva does not undertake an obligation to update or revise any forward-looking statement.

Cardiva, Boomerang and Boomerang Catalyst System are trademarks/registered trademarks of Cardiva Medical, Inc.

Media Contact:

Glenn Foy, President

Cardiva Medical, Inc.

Phone: 650.964.8900, x 215

Fax: 650.964.8911

glenn_foy@cardivamedical.com


'/>"/>
SOURCE Cardiva Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
4. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
5. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
6. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
7. Medical, Behavioral Woes Can Drive Dogs to Bite
8. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
9. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
10. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
11. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... NJ (PRWEB) March 03, 2015 Today, ... Rice, former Seattle Seahawks wide receiver, announced the donation ... in timing with Brain Injury Awareness Month. In an ... injuries and the importance of brain health, Rice and ... field and the need to make brain health a ...
(Date:3/3/2015)... Oregon (PRWEB) March 03, 2015 Man, ... community leaders to help find cures and ensure access ... quality of life for patents and their families. Through ... maximum impact in the fight for a world without ... the top fundraisers in the country, to be announced ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles criminal ... recently spoke on the radio to give his insights into ... Independent Journal Review radio show “The Right Mics” chose Chambers ... and now as a criminal defense attorney would provide him ... and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... Today the Brain Injury Association of ... skate, snow, water, and motorcycle helmets, announced a partnership ... partnership kicks off with Nutcase donating $2 from each ... to BIAA during the month of March in recognition ... leads the nation in observing Brain Injury Awareness Month ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The human ... of the augmentation market. The wearable augmentation sector is ... of size in the upcoming years. , The ... owing to a big number of new products launches ... American region, high technological advancements as well as the ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2
... Large Acute Pain Prescription Drug ... ... - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today announced that it has ... tramadol-acetaminophen,combination product (study 06CCL3-001)., "Tramadol-acetaminophen combination products have become widely,prescribed ...
... Management Solutions Further Distinguishes Itself by Earning, Microsoft ... ... Networking Solutions, WESTLAKE, Ohio, March 10 Antares ... and,information technology solutions, today announced it has attained Gold,Certified ...
... MADISON, N.J. and SUZHOU, China, March 10 ,Wyeth ... is investing $280 million to,build a state-of-the-art nutritional ... The new facility will primarily,produce infant formula milk ... will be one of the world,s largest nutritional,manufacturing ...
... Pap test results happened after girls and women were given ... at the University of Alabama at Birmingham (UAB). , The ... development of cell changes that lead to cervical disease, the ... results by 43 percent compared to women not given the ...
... D.C. The National Museum of Health and Medicine ... host its ninth annual Brain Awareness Week this March ... Initiatives. Over 800 middle-school students from across the Washington, ... inspire a new generation of scientists interested in the ...
... Hopkins have discovered that two clinically different inherited syndromes ... in the April issue of Nature Genetics, the team ... the total number and strength of genetic alterations an ... of symptoms wide enough to appear like different conditions. ...
Cached Medicine News:Health News:Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen 2Health News:Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen 3Health News:Antares Management Solutions Attains Gold Certified Partner Status in Microsoft Partner Program 2Health News:Antares Management Solutions Attains Gold Certified Partner Status in Microsoft Partner Program 3Health News:Antares Management Solutions Attains Gold Certified Partner Status in Microsoft Partner Program 4Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 2Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 3Health News:HPV vaccine reduces abnormal pap test results 2Health News:National Museum of Health and Medicine hosts Brain Awareness Week 2008 2Health News:Genetic research unveils common origins for distinct clinical diagnoses 2
(Date:3/3/2015)... , March 3, 2015 Actavis plc ... has priced an offering of $21 billion aggregate principal ... a registered public offering to be issued by its ... certain of its other subsidiaries (the "Notes"), as follows: ... PublicFloating Rate Senior Notes* , $500,000,000 , ...
(Date:3/3/2015)...  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ... acute care and gastroenterology, today announced fourth quarter ... grew 15% in 2014 to $37 million, resulting ... per diluted share. At the end of 2014, ... including $55 million in cash and investments, with ...
(Date:3/3/2015)... OTTAWA , March 3, 2015 /CNW/ - ... seized a health product being injected at Art Nails ... , which appeared to be unauthorized as it contained no labelling. ... must be authorized by Health Canada and must have approved labelling. ... Botox that had been administered to consumers. Potential risks associated with ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Advisory - Health product seized from Art Nails in Vancouver 2
... Reportlinker.com announces that a new market research report is ... Powder Inhalation http://www.reportlinker.com/p0369401/Dry-Powder-Inhalation.html ... factors – the growing emphasis on drug self-administration for ... therapeutics, the availability of innovative inhaler device designs - ...
... Feb. 1, 2011 Reportlinker.com announces that a new ... Bevacizumab - Comprehensive patent search ... Eliminate unnecessary risk with the industry benchmark in comprehensive ... updated, professional patent search performed by our expert team, ...
Cached Medicine Technology:Reportlinker Adds Dry Powder Inhalation 2Reportlinker Adds Bevacizumab - Comprehensive Patent Search 2Reportlinker Adds Bevacizumab - Comprehensive Patent Search 3Reportlinker Adds Bevacizumab - Comprehensive Patent Search 4
... numerical list of disease and code numbers ... Pocket PC PDA or Smartphone. The International ... (ICD-9-CM) is based on the World Health ... (ICD-9). ICD-9-CM is the official system of ...
... The Wound Care Manager is ... patient assessment and data management ... This application was developed using ... Care along with the most ...
... specifically for the Palm Organizers to ... rounds. It is intended to record ... that are requested by the senior ... round examinations and to record the ...
... patient tracking and billing. ... complete Handheld application, a ... complete CPT™ and ICD-9-CM ... AMA. Designed for any ...
Medicine Products: